vs
科睿唯安（CLVT）与Liberty Energy Inc.（LBRT）财务数据对比。点击上方公司名可切换其他公司
Liberty Energy Inc.的季度营收约是科睿唯安的1.7倍（$1.0B vs $617.0M），Liberty Energy Inc.净利率更高（2.2% vs 0.5%，领先1.7%），Liberty Energy Inc.同比增速更快（4.5% vs -6.9%），过去两年科睿唯安的营收复合增速更高（-0.3% vs -6.2%）
科睿唯安是一家英美合资的上市分析服务企业，主要提供订阅制信息服务，覆盖文献计量、科学计量、商业与市场情报领域，同时为医药、生物科技行业提供专利、监管合规相关的竞争分析，也提供商标保护、域名与品牌保护服务，旗下Web of Science产品系列还负责计算学术期刊的影响因子。
Liberty Energy Inc.是北美领先的能源服务供应商，专注为油气运营企业提供水力压裂及完井解决方案，服务覆盖美国主要页岩产区，供应低排放作业设备及定制化支持，帮助提升油气井生产效率。
CLVT vs LBRT — 直观对比
营收规模更大
LBRT
是对方的1.7倍
$617.0M
营收增速更快
LBRT
高出11.4%
-6.9%
净利率更高
LBRT
高出1.7%
0.5%
两年增速更快
CLVT
近两年复合增速
-6.2%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $617.0M | $1.0B |
| 净利润 | $3.1M | $22.6M |
| 毛利率 | 66.8% | — |
| 营业利润率 | 6.7% | 2.2% |
| 净利率 | 0.5% | 2.2% |
| 营收同比 | -6.9% | 4.5% |
| 净利润同比 | 101.6% | 64.8% |
| 每股收益（稀释后） | $0.00 | $0.14 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CLVTLBRT
| Q1 26 | — | $1.0B | ||
| Q4 25 | $617.0M | $1.0B | ||
| Q3 25 | $623.1M | $947.4M | ||
| Q2 25 | $621.4M | $1.0B | ||
| Q1 25 | $593.7M | $977.5M | ||
| Q4 24 | $663.0M | $943.6M | ||
| Q3 24 | $622.2M | $1.1B | ||
| Q2 24 | $650.3M | $1.2B |
净利润CLVTLBRT
| Q1 26 | — | $22.6M | ||
| Q4 25 | $3.1M | $13.7M | ||
| Q3 25 | $-28.3M | $43.1M | ||
| Q2 25 | $-72.0M | $71.0M | ||
| Q1 25 | $-103.9M | $20.1M | ||
| Q4 24 | $-191.8M | $51.9M | ||
| Q3 24 | $-65.6M | $73.8M | ||
| Q2 24 | $-304.3M | $108.4M |
毛利率CLVTLBRT
| Q1 26 | — | — | ||
| Q4 25 | 66.8% | 20.6% | ||
| Q3 25 | 65.0% | 18.7% | ||
| Q2 25 | 67.2% | 22.1% | ||
| Q1 25 | 65.1% | 22.1% | ||
| Q4 24 | 65.7% | 21.4% | ||
| Q3 24 | 66.2% | 26.2% | ||
| Q2 24 | 67.2% | 27.9% |
营业利润率CLVTLBRT
| Q1 26 | — | 2.2% | ||
| Q4 25 | 6.7% | 1.9% | ||
| Q3 25 | 7.1% | -0.3% | ||
| Q2 25 | 1.1% | 3.6% | ||
| Q1 25 | -3.5% | 1.9% | ||
| Q4 24 | -9.4% | 2.6% | ||
| Q3 24 | 3.5% | 9.4% | ||
| Q2 24 | -36.9% | 12.2% |
净利率CLVTLBRT
| Q1 26 | — | 2.2% | ||
| Q4 25 | 0.5% | 1.3% | ||
| Q3 25 | -4.5% | 4.5% | ||
| Q2 25 | -11.6% | 6.8% | ||
| Q1 25 | -17.5% | 2.1% | ||
| Q4 24 | -28.9% | 5.5% | ||
| Q3 24 | -10.5% | 6.5% | ||
| Q2 24 | -46.8% | 9.3% |
每股收益（稀释后）CLVTLBRT
| Q1 26 | — | $0.14 | ||
| Q4 25 | $0.00 | $0.08 | ||
| Q3 25 | $-0.04 | $0.26 | ||
| Q2 25 | $-0.11 | $0.43 | ||
| Q1 25 | $-0.15 | $0.12 | ||
| Q4 24 | $-0.27 | $0.31 | ||
| Q3 24 | $-0.09 | $0.44 | ||
| Q2 24 | $-0.46 | $0.64 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $329.2M | $699.1M |
| 总债务越低越好 | $4.3B | $7.1M |
| 股东权益账面价值 | $4.8B | $1.9B |
| 总资产 | $11.1B | $4.4B |
| 负债/权益比越低杠杆越低 | 0.89× | 0.00× |
8季度趋势，按日历期对齐
现金及短期投资CLVTLBRT
| Q1 26 | — | $699.1M | ||
| Q4 25 | $329.2M | $27.6M | ||
| Q3 25 | $318.7M | $13.5M | ||
| Q2 25 | $362.6M | $19.6M | ||
| Q1 25 | $354.0M | $24.1M | ||
| Q4 24 | $295.2M | $20.0M | ||
| Q3 24 | $388.5M | $23.0M | ||
| Q2 24 | $376.4M | $30.0M |
总债务CLVTLBRT
| Q1 26 | — | $7.1M | ||
| Q4 25 | $4.3B | $246.6M | ||
| Q3 25 | $4.4B | — | ||
| Q2 25 | $4.5B | — | ||
| Q1 25 | $4.5B | — | ||
| Q4 24 | $4.5B | $190.5M | ||
| Q3 24 | $4.6B | — | ||
| Q2 24 | $4.6B | — |
股东权益CLVTLBRT
| Q1 26 | — | $1.9B | ||
| Q4 25 | $4.8B | $2.1B | ||
| Q3 25 | $4.9B | $2.1B | ||
| Q2 25 | $5.0B | $2.0B | ||
| Q1 25 | $5.0B | $2.0B | ||
| Q4 24 | $5.1B | $2.0B | ||
| Q3 24 | $5.5B | $2.0B | ||
| Q2 24 | $5.6B | $1.9B |
总资产CLVTLBRT
| Q1 26 | — | $4.4B | ||
| Q4 25 | $11.1B | $3.6B | ||
| Q3 25 | $11.2B | $3.5B | ||
| Q2 25 | $11.4B | $3.4B | ||
| Q1 25 | $11.5B | $3.4B | ||
| Q4 24 | $11.5B | $3.3B | ||
| Q3 24 | $12.0B | $3.3B | ||
| Q2 24 | $12.1B | $3.2B |
负债/权益比CLVTLBRT
| Q1 26 | — | 0.00× | ||
| Q4 25 | 0.89× | 0.12× | ||
| Q3 25 | 0.90× | — | ||
| Q2 25 | 0.90× | — | ||
| Q1 25 | 0.90× | — | ||
| Q4 24 | 0.88× | 0.10× | ||
| Q3 24 | 0.84× | — | ||
| Q2 24 | 0.83× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $159.9M | — |
| 自由现金流经营现金流 - 资本支出 | $89.2M | — |
| 自由现金流率自由现金流/营收 | 14.5% | — |
| 资本支出强度资本支出/营收 | 11.5% | 13.1% |
| 现金转化率经营现金流/净利润 | 51.58× | — |
| 过去12个月自由现金流最近4个季度 | $365.3M | — |
8季度趋势，按日历期对齐
经营现金流CLVTLBRT
| Q1 26 | — | — | ||
| Q4 25 | $159.9M | $195.4M | ||
| Q3 25 | $181.1M | $51.5M | ||
| Q2 25 | $116.3M | $170.6M | ||
| Q1 25 | $171.2M | $192.1M | ||
| Q4 24 | $141.3M | $177.3M | ||
| Q3 24 | $202.9M | $244.5M | ||
| Q2 24 | $126.2M | $248.2M |
自由现金流CLVTLBRT
| Q1 26 | — | — | ||
| Q4 25 | $89.2M | $-10.0M | ||
| Q3 25 | $115.5M | $-67.2M | ||
| Q2 25 | $50.3M | $33.1M | ||
| Q1 25 | $110.3M | $58.2M | ||
| Q4 24 | $59.1M | $-26.2M | ||
| Q3 24 | $126.3M | $77.9M | ||
| Q2 24 | $60.3M | $112.2M |
自由现金流率CLVTLBRT
| Q1 26 | — | — | ||
| Q4 25 | 14.5% | -1.0% | ||
| Q3 25 | 18.5% | -7.1% | ||
| Q2 25 | 8.1% | 3.2% | ||
| Q1 25 | 18.6% | 6.0% | ||
| Q4 24 | 8.9% | -2.8% | ||
| Q3 24 | 20.3% | 6.8% | ||
| Q2 24 | 9.3% | 9.7% |
资本支出强度CLVTLBRT
| Q1 26 | — | 13.1% | ||
| Q4 25 | 11.5% | 19.8% | ||
| Q3 25 | 10.5% | 12.5% | ||
| Q2 25 | 10.6% | 13.2% | ||
| Q1 25 | 10.3% | 13.7% | ||
| Q4 24 | 12.4% | 21.6% | ||
| Q3 24 | 12.3% | 14.6% | ||
| Q2 24 | 10.1% | 11.7% |
现金转化率CLVTLBRT
| Q1 26 | — | — | ||
| Q4 25 | 51.58× | 14.28× | ||
| Q3 25 | — | 1.20× | ||
| Q2 25 | — | 2.40× | ||
| Q1 25 | — | 9.55× | ||
| Q4 24 | — | 3.42× | ||
| Q3 24 | — | 3.31× | ||
| Q2 24 | — | 2.29× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CLVT
| Academia Government Group | $312.3M | 51% |
| Re Occurring Revenues | $114.1M | 18% |
| Life Sciences And Healthcare Group | $98.3M | 16% |
| Transactional Revenues | $97.1M | 16% |
LBRT
暂无分部数据
